Clinical Trials Directory

Trials / Sponsors / Theravia

Theravia

Industry · 8 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingPharmacokinetics, Efficacy and Safety of Twice Daily Dosing Regimen of Hydroxycarbamide Dispersible Tablets in
Sickle Cell Disease
Phase 22025-01-21
CompletedAcceptability of a New Paediatric Formulation of Hydroxycarbamide in Children With Sickle Cell Disease.
Sickle Cell Disease
Phase 22022-07-08
CompletedA Bioequivalence Study to Compare the Pharmacokinetics of Two Formulations of Siklos® in Healthy Volunteers
Healthy Volunteers
Phase 12021-08-22
Active Not RecruitingESCORT-HU Extension: European Sickle Cell Disease Cohort - Hydroxyurea - Extension Study
Sickle Cell Disease
—2020-08-21
CompletedSIKAMIC (SIklos on Kidney Function and AlbuMInuria Clinical Trial)
Sickle Cell Disease
Phase 22019-05-28
CompletedPlasma DNA and Vascular Remodelling in Patients With Sickle Cell Disease
Sickle Cell Disease
N/A2016-05-17
CompletedEvaluation of the Impact of Renal Function on the Pharmacokinetics of SIKLOS ® (DARH)
Sickle Cell Disease, Renal Function Disorder
Phase 42015-09-03
CompletedEuropean Sickle Cell Disease Cohort - Hydroxyurea
Sickle Cell Disease
—2009-01-01